Evidence map›Paper›PMID 41709130›Full record

ReviewThe journal of headache and pain2026

Premonitory phase in primary headaches: shared and divergent mechanisms in migraine and cluster headache, the Junior Editorial Board Members' vision.

Jr-Wei Wu, Linda Al-Hassany, Matteo Castaldo, Chia-Chun Chiang, Alejandro Labastida-Ramirez, Roberta Messina, Li-Ling Hope Pan, Doga Vuralli, William Wells-Gatnik, Sophie Merve Yener and 1 more

Abstract readReview
In one paragraph

Review in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jr-Wei WuDepartment of Neurology, Taipei Veterans General Hospital, Taipei, Taiwan. bohemianwu@gmail.com.
Linda Al-HassanyDivision of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Matteo CastaldoHeadache Center, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Chia-Chun ChiangDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Alejandro Labastida-RamirezDivision of Neuroscience, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.
Roberta MessinaVita-Salute San Raffaele University, Milan, Italy.
Li-Ling Hope PanBrain Research Center, National Yang Ming Chiao Tung University, Taipei City, Taiwan.
Doga VuralliDepartment of Neurology and Algology, Faculty of Medicine, Gazi University, Ankara, Türkiye, Turkey.
William Wells-GatnikDepartment of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Sophie Merve YenerDepartment of Neurology, Monash Health, Melbourne, Australia.
Eloísa Rubio-BeltránHeadache Group, Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Guy's Campus, London, SE1 1UL, UK. amada_eloisa.rubio_beltran@kcl.ac.uk.

Funding

Brain Research UK F25-100034Ministry of Science and Technology, Taiwan MOST 111-2314-B-075-064-MY2National Science and Technology Council NSTC 114-2314-B-075-019-MY2National Science and Technology Council NSTC-114-2314-B-A49-038National Science and Technology Council of Taiwan NSTC-113-2314-B-A49-026
6 · The paper itself

Abstract

BACKGROUND AND

aimMigraine and cluster headache are two highly disabling primary headache disorders, each characterized by distinct clinical phases. Both conditions feature a premonitory phase that precedes the onset of pain or the emergence of cluster bouts, and the symptoms occurring during this stage may provide critical insight into their underlying pathophysiology. This narrative review aims to synthesize current evidence on the premonitory phase of migraine and cluster headache, including its clinical manifestations, neurobiological mechanisms, and potential implications for early or pre-emptive therapeutic strategies. MAIN

resultsMigraine patients frequently experience premonitory symptoms before the onset of headache, and multimodal neuroimaging indicates that migraine initiation involves coordinated functional alterations within hypothalamic–brainstem circuits. In cluster headache, premonitory phenomena can be categorized into pre-cluster symptoms, which emerge hours to days before a bout, and pre-attack symptoms, which develop minutes to an hour before an individual attack. Evidence from neuroimaging, genetic, and provocation studies implicates hypothalamic dysfunction, circadian dysregulation, and trigeminal-autonomic network activation as key mechanisms underlying the pre-attack and pre-cluster phases. Across both migraine and cluster headache, early recognition and targeted intervention during the premonitory phase may help prevent or attenuate attacks before the full cascade of nociceptive activation is initiated.

conclusionsThe premonitory phase represents a critical window for understanding the initiation and progression of both migraine and cluster headache. Current evidence suggests that these disorders share partially overlapping neurobiological substrates, particularly involving alterations in hypothalamic function. By elucidating the mechanisms underlying these early phases, future research may help reshape the current clinical paradigm toward truly pre-emptive intervention.

Indexed as

Cluster HeadacheMigraine DisordersProdromal SymptomsHumansCluster headacheMigrainePremonitory phase

Identifiers

PMID41709130
PMCPMC12918035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.